Tradipitant for Nausea and Vomiting
What You Need to Know Before You Apply
What is the purpose of this trial?
The goal of this study is to measure the effects of using Tradipitant to treat nausea and vomiting induced by GLP-1R agonist use in adults with class I or class II obesity, or adults who are overweight with at least one weight-related condition. The study is placebo-controlled with two treatment arms.
Who Is on the Research Team?
Vanda Pharmaceuticals Inc.
Principal Investigator
Vanda Pharmaceuticals Inc.
Are You a Good Fit for This Trial?
Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive either tradipitant or placebo BID for approximately 2 weeks
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Tradipitant
How Is the Trial Designed?
2
Treatment groups
Experimental Treatment
Placebo Group
Treatment with tradipitant BID for approximately 2 weeks
Treatment with placebo BID for approximately 2 weeks
Find a Clinic Near You
Who Is Running the Clinical Trial?
Vanda Pharmaceuticals
Lead Sponsor
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.